Abstract
Cyclin D1 is associated with cell cycle regulation and has more recently been shown to stimulate the transcriptional functions of the oestrogen receptor (ER). Furthermore, in normal breast there is a negative association between expression of ER and the proliferation marker Ki67 indicating that either ER positive cells are non-dividing or that the receptor is down-regulated as cells enter cycle. This important relationship breaks down in many ER-positive cancers and precancerous breast lesions where the receptor is often detected on proliferating cells. The aims of the present study were to determine the interplay between ER, Ki67 and cyclin D1in individual cells within the spectrum of human breast lesions ranging from normal to invasive carcinoma by using dual staining immunofluorescence. We found that in normal breast there was a strong positive association between ER and cyclin D1expression. In contrast there was a strong negative association between cyclin D1and Ki67 expression. Similar findings were seen for the other precancerous and cancerous breast lesions. Thus immunodetectable cyclin D1within individual cells does not appear to be associated with cell cycle progression in the benign or malignant breast but instead may have important interactions with ER. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alle KM, Henshall SM, Field AS and Sutherland RL (1998) Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4: 847–854
Baak JPA and Oort J (1983) A manual of morphometry in diagnostic pathology Springer: Heidelberg, Berlin, New York
Barnes DM (1997) Cyclin D1in mammary carcinoma. J Pathol 181: 267–269
Clarke RB, Howell A, Potten CS and Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987–4991
de Jong JS, van Diest PJ, Michalides RJAM and Baak JPA (1999) Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. J Clin Pathol: Mol Pathol 52: 78–83
Gillett CE, Lee AHS, Millis RR and Barnes DM (1998) Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 184: 396–400
Han EK, Sgambato A, Jiang W, Zhang YJ, Santella RM, Doki Y, Cacace AM, Schieren I and Weinstein IB (1995) Stable overexpression of cyclin D1 in human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 10: 953–961
Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J and Roos G (1997) Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 57: 549–554
Leong AC, Hanby AM, Potts HW, Tan DS, Skilton D, Ryder K, Harris WH, Liebmann RD, Barnes DM and Gillett CE (2000) Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast. Int J Cancer 89: 26–31
Mommers ECM, van Diest PJ, Leonhart AM, Meijer CJLM and Baak JPA (1998) Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast. Hum Pathol 29: 1539–1545
National co-ordinating group for breast screening pathology (1997) Pathology reporting in breast cancer screening Sheffield, UK
Page DL and Rogers LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 23: 1095–1097
Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MPA, Sibson DR and Sloane JP (1999a) Oestrogen receptor- positive proliferating cells in the normal and precancerous breast. Am J Pathol 155: 1811–1815
Shoker BS, Jarvis C, Sibson DR, Walker C and Sloane JP (1999b) Oestrogen receptor expression in the normal and precancerous breast. J Pathol 188: 237–244
Shoker BS, Jarvis C, Clarke RB, Anderson E, Munro C, Davies MPA, Sibson DR and Sloane JP (2000) Abnormal regulation of oestrogen receptor in benign breast lesions. J Clin Pathol 53: 778–783
Sutherland RL, Hamilton JA, Sweeney KJE, Watts CKW and Musgrove EA (1995) Expression and regulation of cyclin genes in breast cancer. Acta Oncol 34: 651–656
van Diest PJ, Michalides RJ, Jannink L, van der Valk P, Peterse HL, de Jong JS, Meijer CJ and Baak JP (1997) Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 150: 705–711
Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV- cyclin D1 transgenic mice. Nature 369: 669–671
Weinstat-Saslow D, Merino MJ, Manrow RE, Lawerence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL and Steeg PS (1995) Overexpression of cyclin D messenger RNA distinguishes invasive and in situ breast carcinomas from non malignant lesions. Nat Med 1: 1257–1260
Zajchowski DA, Sager R and Webster L (1993) Oestrogen inhibits the growth of oestrogen receptor-negative, but not oestrogen receptor-positive, human mammary epithelial cells expressing a recombinant oestrogen receptor. Cancer Res 53: 5004–5011
Zhu XL, Hartwick W, Rohan T and Kandel R (1998) Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol 11: 1082–1088
Zwijsen RML, Wientjens E, Klompmaker R, van der Sman J, Bernards R and Michalides RJAM (1997) CDK-independent activation of oestrogen receptor by cyclin D1. Cell 88: 405–415
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Shoker, B., Jarvis, C., Davies, M. et al. Immunodetectable cyclin D1is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br J Cancer 84, 1064–1069 (2001). https://doi.org/10.1054/bjoc.2001.1705
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1705
Keywords
This article is cited by
-
Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer
Medical Oncology (2016)
-
Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case–control study from the Mayo Benign Breast Disease Cohort
Breast Cancer Research and Treatment (2015)
-
ER and PR signaling nodes during mammary gland development
Breast Cancer Research (2012)
-
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia
Breast Cancer Research and Treatment (2010)
-
Loss of cyclin D1 in concert with deregulated estrogen receptor α expression induces DNA damage response activation and interrupts mammary gland morphogenesis
Oncogene (2008)